ASSEMBLY BIOSCIENCES, INC. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Assembly Biosciences, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Assembly Biosciences, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 1, 2024 was 6.36M shares, a 90.3% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 6.36M -59.4M -90.3% Nov 1, 2024 10-Q 2024-11-07
Q2 2024 6.35M -46.3M -87.9% Aug 2, 2024 10-Q 2024-08-08
Q1 2024 5.48M -46.5M -89.4% Mar 22, 2024 10-K 2024-03-28
Q3 2023 65.7M +16.9M +34.7% Oct 27, 2023 10-Q 2023-11-08
Q2 2023 52.6M +4.18M +8.62% Aug 4, 2023 10-Q 2023-08-09
Q1 2023 51.9M +3.83M +7.95% Mar 20, 2023 10-K 2023-03-22
Q3 2022 48.8M +918K +1.92% Nov 3, 2022 10-Q 2022-11-08
Q2 2022 48.4M +3.47M +7.71% Aug 4, 2022 10-Q 2022-08-09
Q1 2022 48.1M +7.96M +19.8% Feb 28, 2022 10-K 2022-03-11
Q3 2021 47.9M +14.8M +44.9% Nov 1, 2021 10-Q 2021-11-04
Q2 2021 45M +12.1M +36.9% Aug 2, 2021 10-Q 2021-08-05
Q1 2021 40.2M +7.53M +23.1% May 3, 2021 10-Q 2021-05-06
Q3 2020 33M +6.98M +26.8% Nov 2, 2020 10-Q 2020-11-05
Q2 2020 32.9M +7.14M +27.8% Aug 3, 2020 10-Q 2020-08-05
Q1 2020 32.6M +7.08M +27.7% Mar 2, 2020 10-K 2020-03-04
Q3 2019 26M +584K +2.29% Nov 4, 2019 10-Q 2019-11-07
Q2 2019 25.7M +265K +1.04% Jul 31, 2019 10-Q 2019-08-05
Q1 2019 25.5M +5.29M +26.1% Feb 25, 2019 10-K 2019-02-28
Q3 2018 25.5M +8.07M +46.4% Nov 5, 2018 10-Q 2018-11-08
Q2 2018 25.4M +8.08M +46.5% Aug 7, 2018 10-Q 2018-08-08
Q1 2018 20.3M +2.91M +16.7% Mar 5, 2018 10-K 2018-03-08
Q3 2017 17.4M +172K +1% Oct 27, 2017 10-Q 2017-11-01
Q2 2017 17.4M +139K +0.81% Aug 3, 2017 10-Q 2017-08-09
Q1 2017 17.3M +120K +0.7% May 4, 2017 10-Q 2017-05-08
Q3 2016 17.2M -108 0% Nov 3, 2016 10-Q 2016-11-09
Q2 2016 17.2M +35.6K +0.21% Aug 5, 2016 10-Q 2016-08-09
Q1 2016 17.2M +6.53M +61.1% Mar 7, 2016 10-K 2016-03-11
Q3 2015 17.2M +6.58M +61.8% Nov 5, 2015 10-Q 2015-11-09
Q2 2015 17.2M +8.5M +97.9% Aug 10, 2015 10-Q 2015-08-13
Q1 2015 10.7M -12.7M -54.3% Mar 10, 2015 10-K/A 2015-03-16
Q3 2014 10.6M -10.2M -49% Nov 10, 2014 10-Q 2014-11-17
Q2 2014 8.69M -10.9M -55.7% Aug 11, 2014 10-Q 2014-08-14
Q1 2014 23.4M +3.79M +19.3% Mar 24, 2014 10-K 2014-03-31
Q3 2013 20.9M +7.92M +61.3% Nov 8, 2013 10-Q 2013-11-12
Q2 2013 19.6M +6.67M +51.6% Aug 9, 2013 10-Q 2013-08-09
Q1 2013 19.6M +7.2M +58% Mar 12, 2013 10-K 2013-03-18
Q3 2012 12.9M +528K +4.26% Nov 9, 2012 10-Q 2012-11-13
Q2 2012 12.9M +530K +4.27% Aug 2, 2012 10-Q 2012-08-09
Q1 2012 12.4M Mar 8, 2012 10-K 2012-03-14
Q3 2011 12.4M Nov 7, 2011 10-Q/A 2011-11-18
Q2 2011 12.4M Aug 11, 2011 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.